Referenzen
-
1
Atkins D, Best D, Briss P A. et al .
Grading quality of evidence and strength
of recommendations.
BMJ.
2004;
328
(7454)
1490-1494
-
2
Bekkering G E, Kleijnen J.
Verfahrensweisen und
Methoden zur Nutzenbewertung von Arzneimitteln in Deutschland.
Dsch MedWochenschr.
2008;
133
S221-248
-
3
Guyatt G H, Oxman A D, Vist G E. et al .
GRADE: an emerging consensus
on rating quality of evidence and strength of recommendations.
BMJ.
2008;
336
924-6
-
4
Guyatt G H, Oxman A D, Kunz R, Vist G E, Falck-Ytter Y, Schunemann H J.
What is „quality
of evidence” and why is it important to clinicians?.
BMJ.
2008;
336
995-998
-
5
Guyatt G H, Oxman A D, Kunz R. et al .
Incorporating considerations of resources
use into grading recommendations.
BMJ.
2008;
336
1170-1173
-
6
Guyatt G H, Oxman A D, Kunz R. et al .
Going from evidence to recommendations.
BMJ.
2008;
336
1049-1051
-
7
Schunemann H J, Oxman A D, Brozek J. et al .
Grading quality of evidence and strength
of recommendations for diagnostic tests and strategies.
BMJ.
2008;
336
1106-1110
-
8
Schunemann H J, Jaeschke R, Cook D J. et al .
An official ATS statement: grading the
quality of evidence and strength of recommendations in ATS guidelines
and recommendations.
Am J Respir Crit Care Med.
2006;
174
605-614
-
9
Schunemann H J, Best D, Vist G, Oxman A D.
Letters, numbers,
symbols and words: how to communicate grades of evidence and recommendations.
Cmaj.
2003;
169
677-680
Prof. Dr. med. Holger J. SchünemannM.Sc., Ph. D.
Chair, Department
of Clinical Epidemiology & Biostatistics
Michael Gent Chair in Healthcare Research, Professor of
Clinical Epidemiology/Biostatistics/Medicine, McMaster
University, Hamilton, Kanada
Prof. Dr. Regina Kunz, M.Sc.
Institut für Klinische Epidemiologie, Universitätsspital
Basel
Hebelstrasse 10
4031 Basel
Schweiz
Asst. Prof. Dr. med. Yngve Falck-Ytter
Case Western Reserve University Cleveland, VA
Medical Center Cleveland
10701 East Blvd.
Cleveland,
OH, 44106, USA
